Tarragona, Spain

Lluis Solá Carandell

This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lluis Solá Carandell. Retrieved from https://idiyas.com/inventor/lluis-solá-carandell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lluis Solá Carandell: Innovator in Pharmaceutical Co-Crystals

Introduction

Lluis Solá Carandell is a notable inventor based in Tarragona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for pain treatment. His innovative work has the potential to enhance the efficacy of existing medications.

Latest Patents

One of Lluis Solá Carandell's key patents is titled "Co-crystals of duloxetine and COX-INHIBITORs for the treatment of pain." This invention relates to co-crystals of duloxetine combined with COX-INHIBITORs, which are used in the preparation of medicaments or pharmaceutical formulations aimed at treating pain. The patent highlights the processes for creating these co-crystals and their applications in medical treatments.

Career Highlights

Lluis Solá Carandell is associated with Laboratorios del Dr. Esteve S.A., where he has been instrumental in advancing pharmaceutical research. His work focuses on innovative solutions that address pain management through novel drug formulations.

Collaborations

Throughout his career, Lluis has collaborated with esteemed colleagues, including Helmut Heinrich Buschmann and Jordi Benet Buchholz. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical development.

Conclusion

Lluis Solá Carandell's contributions to the field of pharmaceuticals, particularly through his patent on co-crystals for pain treatment, underscore his role as an innovator. His work continues to influence the development of effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…